nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A familiar species of Crank: Anti-Vaccinationists in medical history
|
Janssen, Diederik F. |
|
|
40 |
31 |
p. 4135-4141 |
artikel |
2 |
Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccines
|
Smith, William J. |
|
|
40 |
31 |
p. 4182-4189 |
artikel |
3 |
Antibody dependent cell cytotoxicity is maintained by the unmutated common ancestor of 6F5, a Gp41 conformational epitope targeting antibody that utilizes heavy chain VH1-2
|
Wrotniak, Brian H. |
|
|
40 |
31 |
p. 4174-4181 |
artikel |
4 |
A scoping review of active, participant-centred, digital adverse events following immunization (AEFI) surveillance: A Canadian immunization research network study
|
Psihogios, Athanasios |
|
|
40 |
31 |
p. 4065-4080 |
artikel |
5 |
Corrigendum to “Variability in non-core vaccination rates of dogs and cats in veterinary clinics across the United States” [Vaccine 40(7) (2022) 1001–1009]
|
Malter, Kyle B. |
|
|
40 |
31 |
p. 4281 |
artikel |
6 |
COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery
|
Toor, Jaspreet |
|
|
40 |
31 |
p. 4142-4149 |
artikel |
7 |
Development and immunogenicity evaluation of porcine deltacoronavirus inactivated vaccine with different adjuvants in mice
|
Zhao, Fu-jie |
|
|
40 |
31 |
p. 4211-4219 |
artikel |
8 |
Editorial Board/Aims and Scope
|
|
|
|
40 |
31 |
p. IFC |
artikel |
9 |
Effectiveness of trivalent influenza vaccines against hospitalizations due to laboratory-confirmed influenza a in the elderly: Comparison of test-negative design with register-based designs
|
Halme, Jussi |
|
|
40 |
31 |
p. 4242-4252 |
artikel |
10 |
Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study
|
Lightowler, Maria S. |
|
|
40 |
31 |
p. 4199-4210 |
artikel |
11 |
Effects of N-acylation on the immune adjuvanticity of analogs of the Quillaja saponins derivative GPI-0100
|
Marciani, Dante J. |
|
|
40 |
31 |
p. 4169-4173 |
artikel |
12 |
Estimating the burden of adult hospitalized RSV infection including special populations
|
Nowalk, Mary Patricia |
|
|
40 |
31 |
p. 4121-4127 |
artikel |
13 |
Evaluation of prime and prime-boost immunization strategies in BALB/c mice inoculated with Leishmania infantum transfected with toxic plasmids
|
Augusto Sanches Roque, Guilherme |
|
|
40 |
31 |
p. 4105-4115 |
artikel |
14 |
Excluding numeric side-effect information produces lower vaccine intentions
|
Shoots-Reinhard, Brittany |
|
|
40 |
31 |
p. 4262-4269 |
artikel |
15 |
Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries
|
Leigh, Jeanna Parsons |
|
|
40 |
31 |
p. 4081-4089 |
artikel |
16 |
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys
|
Hashimoto, Masayuki |
|
|
40 |
31 |
p. 4231-4241 |
artikel |
17 |
Influenza cases in nine aged care facilities in Sydney, Australia over a three-year surveillance period, 2018—2020
|
Kunasekaran, Mohana Priya |
|
|
40 |
31 |
p. 4253-4261 |
artikel |
18 |
Modelling the impact of maternal pneumococcal vaccination on infant pneumococcal disease in low-income settings
|
Bilgin, Gizem M. |
|
|
40 |
31 |
p. 4128-4134 |
artikel |
19 |
Norovirus-VLPs expressing pre-erythrocytic malaria antigens induce functional immunity against sporozoite infection
|
Schneider, Cosette G. |
|
|
40 |
31 |
p. 4270-4280 |
artikel |
20 |
Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years
|
Chichili, Gurunadh R. |
|
|
40 |
31 |
p. 4190-4198 |
artikel |
21 |
Recombinant Aspergillus fumigatus antigens Asp f 3 and Asp f 9 in liposomal vaccine protect mice against invasive pulmonary aspergillosis
|
Slarve, Matthew |
|
|
40 |
31 |
p. 4160-4168 |
artikel |
22 |
Relationship between the use of nonpharmaceutical interventions and COVID-19 vaccination among U.S. child care providers: A prospective cohort study
|
Patel, Kavin M. |
|
|
40 |
31 |
p. 4098-4104 |
artikel |
23 |
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials
|
Eugenia-Toledo-Romaní, María |
|
|
40 |
31 |
p. 4220-4230 |
artikel |
24 |
Safety and immunogenicity of a quadrivalent seasonal influenza vaccine adjuvanted with hydroxypropyl-β-cyclodextrin: A phase 1 clinical trial
|
Watanabe, Akane |
|
|
40 |
31 |
p. 4150-4159 |
artikel |
25 |
Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: Reports to the vaccine adverse event reporting system
|
Woo, Emily Jane |
|
|
40 |
31 |
p. 4116-4120 |
artikel |
26 |
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment
|
Salmanton-García, Jon |
|
|
40 |
31 |
p. 4090-4097 |
artikel |